Horizontal transmission of Marek's disease virus requires US2, the UL13 protein kinase, and gC

Journal of Virology

Volumn 81, Issue 19, 2007, Pages 10575-10587

  Jarosinski, Keith W ^a   Margulis, Neil G ^a   Kamil, Jeremy P ^a   Spatz, Stephen J ^b   Nair, Venugopal K ^c   Osterrieder, Nikolaus ^a  

^a Department of Obstetrics Gynecology   (United States)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

^c INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN D; PROTEIN C; PROTEIN SERINE THREONINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AVIAN LYMPHOMATOSIS HERPETOVIRUS; BACTERIAL ARTIFICIAL CHROMOSOME; BIRD DISEASE; CHICKEN; CONTROLLED STUDY; EMBRYO; EPITHELIUM CELL; FRAMESHIFT MUTATION; GENETIC MANIPULATION; MALAISE; MOLECULAR CLONING; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; U L 13 GENE; U L 44 GENE; U S 6 GENE; VIREMIA; VIRUS GENE; VIRUS GENOME; VIRUS REPLICATION; VIRUS TRANSMISSION; VIRUS VIRULENCE;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, VIRAL; BASE SEQUENCE; CHICKENS; CLONING, MOLECULAR; DISEASE TRANSMISSION, INFECTIOUS; DNA REPAIR; GENOME, VIRAL; MARDIVIRUS; MAREK DISEASE; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN-SERINE-THREONINE KINASES; VIRAL ENVELOPE PROTEINS; VIRAL PROTEINS; VIRUS REPLICATION;

BACTERIA (MICROORGANISMS); GALLID HERPESVIRUS 2; GALLUS GALLUS;

EID: 34648824632     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01065-07     Document Type: Article

References (55)

1. Anderson, A. S., M. S. Parcells, and R. W. Morgan. 1998. The glycoprotein D (US6) homolog is not essential for oncogenicity or horizontal transmission of Marek's disease virus. J. Virol. 72:2548-2553.
2. Blondeau, C., N. Chbab, C. Beaumont, K. Courvoisier, N. Osterrieder, J. F. Vautherot, and C. Denesvre. 2007. A full UL13 open reading frame in Marek's disease virus (MDV) is dispensable for tumor formation and feather follicle tropism and cannot restore horizontal spread in rRB-1B in vivo. Vet. Res. 38:419-433.
3. Brown, A. C., S. J. Baigent, L. P. Smith, J. P. Chattoo, L. J. Petherbridge, P. Hawes, M. J. Allday, and V. Nair. 2006. Interaction of MEQ protein and C-terminal-binding protein is critical for induction of lymphomas by Marek's disease virus. Proc. Natl. Acad. Sci. USA 103:1687-1692.
4. Calnek, B. W. 2001. Pathogenesis of Marek's disease virus infection, p. 25-55. In K. Hirai (ed.), Marek's disease. Springer, Berlin, Germany.
5. Cohen, J. I., and K. Seidel. 1994. Varicella-zoster virus (VZV) open reading frame 10 protein, the homolog of the essential herpes simplex virus protein VP16, is dispensable for VZV replication in vitro. J. Virol. 68:7850-7858.
6. Cunningham, C., A. J. Davison, A. Dolan, M. C. Frame, D. J. McGeoch, D. M. Meredith, H. W. M. Moss, and A. C. Orr. 1992. The UL13 virion protein of herpes simplex virus type 1 is phosphoiylated by a novel virus-induced protein kinase. J. Gen. Virol. 73:303-311.
7. Davison, A. J., and J. E. Scott. 1986. The complete DNA sequence of varicella-zoster virus. J. Gen. Virol. 67:1759-1816.
8. de Wind, N., A. Zijderveld, K. Glazenburg, A. Gielkens, and A. Berns. 1990. Linker insertion mutagenesis of herpesviruses: inactivation of single genes within the Us region of pseudorabies virus. J. Virol. 64:4691-4696.
9. Dorange, F., B. K. Tischer, J. F. Vautherot, and N. Osterrieder. 2002. Characterization of Marek's disease virus serotype 1 (MDV-1) deletion mutants that lack UL46 to UL49 genes: MDV-1 UL49, encoding VP22, is indispensable for virus growth. J. Virol. 76:1959-1970.
10. Feenstra, V., M. Hodaie, and D. C. Johnson. 1990. Deletions in herpes simplex virus glycoprotein D define nonessential and essential domains. J. Virol. 64:2096-2102.
11. Fuchs, W., H. Granzow, B. G. Klupp, M. Kopp, and T. C. Mettenleiter. 2002. The UL48 tegument protein of pseudorabies virus is critical for intracytoplasmic assembly of infectious virions. J. Virol. 76:6729-6742.
12. Fuchs, W., B. G. Klupp, H. Granzow, C. Hengartner, A. Brack, A. Mundt, L. W. Enquist, and T. C. Mettenleiter. 2002. Physical interaction between envelope glycoproteins E and M of pseudorabies virus and the major tegument protein UL49. J. Virol. 76:8208-8217.
13. Jarosinski, K. W., N. Osterrieder, V. K. Nair, and K. A. Schat. 2005. Attenuation of Marek's disease virus by deletion of open reading frame RLORF4 but not RLORF5a. J. Virol. 79:11647-11659.
14. Jarosinski, K. W., R. Yunis, P. H. O'Connell, C. J. Markowski-Grimsrud, and K. A. Schat. 2002. Influence of genetic resistance of the chicken and virulence of Marek's disease virus (MDV) on nitric oxide responses after MDV infection. Avian Dis. 46:636-649.
15. Kamil, J. P., B. K. Tischer, S. Trapp, V. K. Nair, N. Osterrieder, and H. J. Kung. 2005. vLIP, a viral lipase homologue, is a virulence factor of Marek's disease virus. J. Virol. 79:6984-6996.
16. Karger, A., and T. C. Mettenleiter. 1993. Glycoprotein-gIII and glycoprotein-gp50 play dominant roles in the biphasic attachment of pseudorabies virus. Virology 194:654-664.
17. Kato, A., M. Yamamoto, T. Ohno, M. Tanaka, T. Sata, Y. Nishiyama, and Y. Kawaguchi. 2006. Herpes simplex virus 1-encoded protein kinase UL13 phosphorylates viral Us3 protein kinase and regulates nuclear localization of viral envelopment factors UL34 and UL31. J. Virol. 80:1476-1486.
18. Levy, A. M., O. Gilad, L. Xia, Y. Izumiya, J. Choi, A. Tsalenko, Z. Yakhini, R. Witter, L. Lee, C. J. Cardona, and H. J. Kung. 2005. Marek's disease virus Meq transforms chicken cells via the v-Jun transcriptional cascade: a converging transforming pathway for avian oncoviruses. Proc. Natl. Acad. Sci. USA 102:14831-14836.
19. Liang, X. P., C. Pyne, Y. H. Li, L. A. Babiuk, and J. Kowalski. 1995. Delineation of the essential function of bovine herpesvirus-1 gD - an indication for the modulatory role of gD in virus entry. Virology 207:429-441.
20. Liu, J. L., Y. Ye, L. F. Lee, and H. J. Kung. 1998. Transforming potential of the herpesvirus oncoprotein MEQ: morphological transformation, serum-independent growth, and inhibition of apoptosis. J. Virol. 72:388-395.
21. Longnecker, R., and B. Roizman. 1987. Clustering of genes dispensable for growth in culture in the S-component of the HSV-1 genome. Science 236: 573-576.
22. McGeoch, D. J. 1990. Evolutionary relationships of virion glycoprotein genes in the S regions of alphaherpesvirus genomes. J. Gen. Virol. 71:2361-2367.
23. McGeoch, D. J., A. Dolan, S. Donald, and F. J. Rixon. 1985. Sequence determination and genetic content of the short unique region in the genome of herpes simplex virus type 1. J. Mol. Biol. 181:1-13.
24. S2 homolog encodes a nonessential membrane-associated virion component. J. Virol. 73:3430-3437.
25. Mettenleiter, T. C. 1989. Glycoprotein gIII deletion mutants of pseudorabies virus are impaired in virus entry. Virology 171:623-625.
26. Moffat, J. F., L. Zerboni, P. R. Kinchington, C. Grose, H. Kaneshima, and A. M. Arvin. 1998. Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse. J. Virol. 72:965-974.
27. Moffat, J. F., L. Zerboni, M. H. Sommer, T. C. Heineman, J. I. Cohen, H. Kaneshima, and A. M. Arvin. 1998. The ORF47 and ORF66 putative protein kinases of varicella-zoster virus determine tropism for human T cells and skin in the SCID-hu mouse. Proc. Natl. Acad. Sci. USA 95:11969-11974.
28. Morgan, R. W., A. Anderson, J. Kent, and M. Parcells. 1996. Characterization of Marek's disease virus RB1B-based mutants having disrupted glycoprotein C or glycoprotein D homolog genes, p. 207-212. In Current research on Marek's disease: proceedings of the 5th International Symposium on Marek's Disease. American Association of Avian Pathologists, Kennett Square, PA.
29. Ng, T. I., W. O. Ogle, and B. Roizman. 1998. U(L)13 protein kinase of herpes simplex virus 1 complexes with glycoprotein E and mediates the phosphorylation of the viral Fc receptor: glycoproteins E and I. Virology 241:37-48.
30. Niikura, M., J. Dodgson, and H. Cheng. 2006. Direct evidence of host genome acquisition by the alphaherpesvirus Marek's disease virus. Arch. Virol. 151:537-549.
31. Niikura, M., R. L. Witter, H. K. Jang, M. Ono, T. Mikami, and R. F. Silva. 1999. MDV glycoprotein D is expressed in the feather follicle epithelium of infected chickens. Acta Virol. 43:159-163.
32. Ogle, W. O., T. I. Ng, K. L. Carter, and B. Roizman. 1997. The U(L)13 protein kinase and the infected cell type are determinants of posttranslational modification of ICP0. Virology 235:406-413.
33. Ohashi, K., P. H. O'Connell, and K. A. Schat. 1994. Characterization of Marek's disease virus BamHI-A-specific cDNA clones obtained from a Marek's disease lymphoblastoid cell line. Virology 199:275-283.
34. Osterrieder, N. 1999. Construction and characterization of an equine herpesvirus 1 glycoprotein C negative mutant. Virus Res. 59:165-177.
35. Osterrieder, N., J. P. Kamil, D. Schumacher, B. K. Tischer, and S. Trapp. 2006. Marek's disease virus: from miasma to model. Nat. Rev. Microbiol. 4:283-294.
36. Parcells, M. S., A. S. Anderson, J. L. Cantello, and R. W. Morgan. 1994. Characterization of Marek's disease virus insertion and deletion mutants that lack US1 (ICP22 homolog), US10, and/or US2 and neighboring short-component open reading frames. J. Virol. 68:8239-8253.
37. Petherbridge, L., K. Howes, S. Baigent, S. Evans, M. Sacco, N. Osterrieder, and V. Nair. 2003. Replication-competent bacterial artificial chromosomes of Marek's disease virus: novel tools for generation of molecularly defined herpesvirus vaccines. J. Virol. 77:8712-8718.
38. Petherbridge, L., A. C. Brown, S. J. Baigent, K. Howes, M. A. Sacco, N. Osterrieder, and V. K. Nair. 2004. Oncogenicity of virulent Marek's disease virus cloned as bacterial artificial chromosomes. J. Virol. 78:13376-13380.
39. Purves, F. C., and B. Roizman. 1992. The UL13 gene of herpes-simplex virus-1 encodes the functions for posttranslational processing associated with phosphorylation of the regulatory protein-alpha-22. Proc. Natl. Acad. Sci. USA 89:7310-7314.
40. Reddy, S. M., B. Lupiani, I. M. Gimeno, R. F. Silva, L. F. Lee, and R. L. Witter. 2002. Rescue of a pathogenic Marek's disease virus with overlapping cosmid DNAs: use of a pp38 mutant to validate the technology for the study of gene function. Proc. Natl. Acad. Sci. USA 99:7054-7059.
41. Rue, C. A., and P. Ryan. 2002. Characterization of pseudorabies virus glycoprotein C attachment to heparan sulfate proteoglycans. J. Gen. Virol. 83:301-309.
42. Schat, K. A., B. W. Calnek, and J. Fabricant. 1982. Characterization of two highly oncogenic strains of Marek's disease virus. Avian Pathol. 11:593-605.
43. Schat, K. A., and H. G. Purchase. 1998. Cell-culture methods, p. 223-234. In D. E. Swayne, J. R. Glisson, M. W. Jackwood, J. E. Pearson, and W. M. Reed (ed.), A laboratory manual for the isolation and identification of avian pathogens. American Association of Avian Pathologists, Kennett Square, PA.
44. Schumacher, D., B. K. Tischer, W. Fuchs, and N. Osterrieder. 2000. Reconstitution of Marek's disease virus serotype 1 (MDV-1) from DNA cloned as a bacterial artificial chromosome and characterization of a glycoprotein B-negative MDV-1 mutant. J. Virol. 74:11088-11098.
45. 44a. Spatz, S. J., Y. Zhao, L. Petherbridge, L. Smith, S. Baigent, and V. K. Nair. 2007. Comparative sequence analysis of a highly oncogenic but horizontal spread-defective clone of Marek's disease virus. Virus Genes, in press.
46. Tischer, B. K., D. Schumacher, D. Chabanne-Vautherot, V. Zelnik, J. F. Vautherot, and N. Osterrieder. 2005. High-level expression of Marek's disease virus glycoprotein C is detrimental to virus growth in vitro. J. Virol. 79:5889-5899.
47. Tischer, B. K., J. von Einem, B. Kaufer, and N. Osterrieder. 2006. Two-step red-mediated recombination for versatile high-efficiency markerless DNA manipulation in Escherichia coli. BioTechniques 40:191-197.
48. Trapp, S., M. S. Parcells, J. P. Kamil, D. Schumacher, B. K. Tischer, P. M. Kumar, V. K. Nair, and N. Osterrieder. 2006. A virus-encoded telomerase RNA promotes malignant T cell lymphomagenesis. J. Exp. Med. 203:1307-1317.
49. Tulman, E. R., C. L. Afonso, Z. Lu, L. Zsak, D. L. Rock, and G. F. Kutish. 2000. The genome of a very virulent Marek's disease virus. J. Virol. 74:7980-7988.
50. von Einem, J., D. Schumacher, D. J. O'Callaghan, and N. Osterrieder. 2006. The α-TIF (VP16) homologue (ETIF) of equine herpesvirus 1 is essential for secondary envelopment and virus egress. J. Virol. 80:2609-2620.
51. Weber, P. C., M. Levine, and J. C. Glorioso. 1987. Rapid identification of nonessential genes of herpes simplex virus type 1 by Tn5 mutagenesis. Science 236:576-579.
52. Whittaker, G. R., L. A. Taylor, D. M. Elton, L. E. Giles, W. A. Bonass, I. W. Halliburton, R. A. Killington, and D. M. Meredith. 1992. Glycoprotein 60 of equine herpesvirus type 1 is a homolog of herpes simplex virus glycoprotein D and plays a major role in penetration of cells. J. Gen. Virol. 73:801-809.
53. Witter, R. L. 2001. Protective efficacy of Marek's disease vaccines, p. 57-90. In K. Hirai (ed.), Marek's disease. Springer, Berlin, Germany.
54. Yunis, R., K. W. Jarosinski, and K. A. Schat. 2004. Association between rate of viral genome replication and virulence of Marek's disease herpesvirus strains. Virology 328:142-150.
55. Zelnik, V., V. Majerciak, D. Szabova, H. Geerligs, J. Kopacek, L. J. N. Ross, and J. Pastorek. 1999. Glycoprotein gD of MDV lacks functions typical for alpha-herpesvirus gD homologues. Acta Virol. 43:164-168.